AI-Assisted Skin Cancer Evaluation
Experience DermaSensor, A fast, painless scan to help identify which skin spots may need closer attention—- available during a routine office visit
DermaSensor is an FDA‑cleared, handheld device that uses light and artificial intelligence to help evaluate suspicious moles and skin lesions in seconds. It is designed to assist in detecting the three most common skin cancers—melanoma, basal cell carcinoma, and squamous cell carcinoma—and to support decisions about whether a spot should be monitored, biopsied, or referred to a dermatologist. At Alternity Healthcare, precision has never been this simple.
How The Technology Works
DermaSensor uses a light‑based method called elastic scattering spectroscopy to examine the microscopic structure of a skin lesion without breaking the skin. The device’s AI algorithm, trained on thousands of previously diagnosed lesions, analyzes the light patterns and returns a risk result within seconds.
The clinician combines this result with your history, risk factors, and a full skin exam to decide whether a lesion is likely safe to monitor or should be investigated further.
Proven, Evidence‑Based Performance
Sensitivity for Skin Cancer Detection
96%
Chance of benign result with negative scan
97%
Patients in FDA clinical studies
1,500+
Lesions evaluated in clinical trials
4,000+
In FDA‑reviewed clinical studies across more than 1,500 patients and over 4,000 lesions, DermaSensor demonstrated high sensitivity for skin cancer detection, correctly identifying about 96% of skin cancers. A negative result has been associated with about a 97% chance that the lesion is benign, which can help reduce unnecessary procedures while still prioritizing safety.
Multiple clinical utility studies show that adding the device to routine practice improves physicians’ ability to correctly identify skin cancers and make appropriate referral decisions.
Benefits For Patients
- Rapid, in‑office information about suspicious spots, without needles or cutting during the scan.
- Support for early detection of melanoma, basal cell carcinoma, and squamous cell carcinoma.
- More confidence in decisions about which lesions should be biopsied or sent to dermatology urgently.
- Fits easily into annual exams or focused skin checks, especially for patients at higher risk.
Who Is A Good Candidate?
DermaSensor is intended for adults with skin lesions that appear suspicious on exam, particularly those 40 years and older. It may be especially helpful for patients with a personal or family history of skin cancer, many atypical moles, fair skin, or significant lifetime sun exposure.
It is an adjunctive tool and does not replace a full skin exam, dermatologist evaluation, or biopsy when indicated.
What To Expect At Your Visit
1. Skin Examination
The clinician will visually examine your skin and identify any lesions that warrant a closer look.
2. Quick Scan
The DermaSensor device is gently placed on the suspicious spot and captures readings using light in just seconds—painless and non-invasive.
3. Review & Decision
You and your clinician review the result together and decide on next steps such as monitoring, or dermatology referral for biopsy.